What is Incyte's deferred tax assets and other non-current assets?

Incyte (INCY) reported deferred tax assets and other non-current assets of $24.49M in Q1 2026.

How has Incyte's deferred tax assets and other non-current assets changed year-over-year?

Incyte's deferred tax assets and other non-current assets decreased by 18.8% year-over-year, from $30.15M to $24.49M.

What is the long-term trend for Incyte's deferred tax assets and other non-current assets?

Over 5 years (2020 to 2025), Incyte's deferred tax assets and other non-current assets has grown at a -14.3% compound annual growth rate (CAGR), from $39.40M to $18.17M.

What does deferred tax assets and other non-current assets mean?

The total value of long-term tax assets and other miscellaneous long-term assets.

Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets

Incyte Deferred Tax Assets and Other Non-Current Assets increased by 34.8% to $24.49M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.8%, from $30.15M to $24.49M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows a downward trend with a -14.3% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryLiquidity

SignalContext dependent

VolatilityStable

First reportedQ4 2015

Last reportedQ1 2026Apr 28, 2026

How to read this metric

An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.

Detailed definition

This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...

Peer comparison

Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.

Metric ID: deferred_tax_assets_other_noncurrent

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$20.45M	$24.79M	$37.30M	$31.42M	$23.01M	$23.67M	$25.44M	$20.72M	$31.71M	$80.96M	$52.11M	$47.40M	$21.92M	$40.38M	$10.85M	$30.15M	$32.55M	$32.30M	$18.17M	$24.49M
QoQ Change	—	+21.2%	+50.5%	-15.8%	-26.8%	+2.8%	+7.5%	-18.5%	+53.0%	+155.3%	-35.6%	-9.0%	-53.8%	+84.2%	-73.1%	+177.9%	+8.0%	-0.8%	-43.8%	+34.8%
YoY Change	—	—	—	—	+12.5%	-4.5%	-31.8%	-34.1%	+37.8%	+242.1%	+104.9%	+128.8%	-30.9%	-50.1%	-79.2%	-36.4%	+48.5%	-20.0%	+67.5%	-18.8%

Range$10.85M – $80.96M

CAGR+3.9%

Avg YoY Growth+21.0%

Median YoY Growth-11.6%

Deferred Tax Assets and Other Non-Current Assets at Other Companies

Bristol-Myers SquibbBMY View metric

PfizerPFE View metric

Gilead SciencesGILD View metric

AbbVieABBV View metric

AmgenAMGN View metric

BiogenBIIB View metric

Frequently Asked Questions

What is Incyte's deferred tax assets and other non-current assets?: Incyte (INCY) reported deferred tax assets and other non-current assets of $24.49M in Q1 2026.
How has Incyte's deferred tax assets and other non-current assets changed year-over-year?: Incyte's deferred tax assets and other non-current assets decreased by 18.8% year-over-year, from $30.15M to $24.49M.
What is the long-term trend for Incyte's deferred tax assets and other non-current assets?: Over 5 years (2020 to 2025), Incyte's deferred tax assets and other non-current assets has grown at a -14.3% compound annual growth rate (CAGR), from $39.40M to $18.17M.
What does deferred tax assets and other non-current assets mean?: The total value of long-term tax assets and other miscellaneous long-term assets.